Search

This health economic report presents a cost effectiveness analysis of introducing chickenpox vaccination for children in Sweden from a societal and healthcare perspective. It also includes analyses of costs and cost-savings at national and regional levels.

The Communicable Diseases Ordinance contains 13 criteria that form the basis of an investigation of vaccination programmes. This knowledge base is a scientific review based on these criteria. 

The Public Health Agency of Sweden has updated the recommendations for mpox vaccination due to increased spread of clade 1.

If you are pregnant, vaccination against whooping cough, influenza is recommended for your sake and that of your baby. Here you can read more about why, as well as what these diseases involve.

This report presents the health economic analyses informing the recommendation of herpes zoster vaccination for adults with increased risk for disease.

This report presents an analysis of COVID-19 vaccine effectiveness (VE) after a fourth dose in relation to SARS-CoV-2 infection and severe outcomes due to the omicron variant among persons aged 65 years and older in Sweden.

This report describes the monitoring and surveillance systems for influenza in use during the 2024–2025 winter season and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons. See also the tables and figures section as well as the

This report describes the monitoring systems for influenza in use during the winter season of 2020–2021 and the results of both epidemiological and virological surveillance. Data are also compared to previous influenza seasons.

This report describes epidemiological and virological surveillance results for the influenza season of 2022–2023 in Sweden. Data are also compared to previous influenza seasons.

This report describes epidemiological and virological surveillance results for the 2023-2024 influenza season in Sweden. Data are also compared to previous influenza seasons.